SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABAX --- lots of upside
ABAX 83.000.0%Aug 1 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Bogdanoff who wrote (441)6/17/1998 5:19:00 PM
From: David Bogdanoff  Read Replies (3) of 492
 
To all;

Does anyone have an opinion on the Origen technology from IGEN International as a competitor to ABAX? According to a June 14 IBD article this technology has a lot of applications for high speed screening of chemicals and with potential applications for clinical POC. In other words, apparently it is a future competitor to ABAX, although the scheduled launch for a POC clinical device is Q1 2001.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext